The application is related to U.S. Pat. No. 7,001,369 and U.S. Patent Application Publication No. US 2006/0264904, the entire disclosures of which are herein incorporated by reference.
The present invention pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present invention pertains to medical devices including a tubular member and a liner disposed within the tubular member.
A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
The invention provides design, material, manufacturing method, and use alternatives for medical devices or components thereof. An example medical device may include a tubular member and a liner disposed within the tubular member. The tubular member may have a plurality of slots formed therein. A space may be defined between the inner surface of the tubular member and the outer surface of the liner. One or more bonding members may be disposed in the space to bond the tubular member to the liner.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Catheter 10 may include a generally elongate shaft 12 having a longitudinal axis X, a proximal portion 14, and a distal portion 16. A proximal manifold 18 may be disposed at proximal portion 14. Manifold 18 may include a hub 20 and strain relief 22. A tip member 24 may be disposed at distal portion 16. Tip member 24 may include a radiopaque marker member 26. One or more additional marker members 26 may be disposed along other portions of catheter 10, for example along distal portion 16 of shaft 12. Shaft 12 may include a tubular member 28 having a plurality of slots 30 formed therein. Tubular member 28 may extend along the entire length of shaft 12 or any suitable portion of the length of shaft 12. Likewise, slots 30 may be disposed along a portion or all of tubular member 28. Some additional details regarding tubular member 28 and slots 30 can be found below.
Turning now to
Liner 32 may generally comprise a polymeric material. Some examples of suitable polymeric materials are listed below. The polymeric material may be selected so as to provide inner surface 36 with the desired amount of lubricity so that devices (e.g., guidewires, etc.) can be manipulated within lumen 38. In some embodiments, liner 32 may be single layer of material. In other embodiments, liner 32 may include a plurality of layers. For example, liner 32 may include an inner layer, an intermediate layer disposed about the inner layer, a reinforcing layer disposed about the intermediate layer, and an outer layer disposed about the reinforcing layer and the intermediate layer. It should be understood that more or fewer layers can be used, with or without one or more reinforcing layers, depending upon the desired characteristics of liner 32. Additionally, in other embodiments, the layers could be arranged differently to achieve desired properties.
In general, along at least a portion of the length of liner 32, outer surface 34 is spaced apart from an inner surface 40 of tubular member 28. In some embodiments, liner 32 is spaced apart from tubular member 28 along the entire length of liner 32. The spacing may define a void or space 42 between the outer surface 34 of liner 32 and the inner surface 40 of tubular member 28. Space 42 may be generally cylindrical in shape, annular in shape, or have any other suitable shape and, as such, it can have or otherwise define a volume.
One or more bonding members 44 may be disposed in space 42. In some embodiments, bonding members 44 are distinct structural elements (e.g., distinct from liner 32 and tubular member 28) that are disposed in space 42. For example, bonding member 44 may include an adhesive, solder, epoxy, a bonding substance, or the like, or any other suitable substance. Alternatively, bonding member 44 may reflect a bonding pattern or bonding region where a portion of liner 32 and/or tubular member 28 extends into space 42 as the result of a bonding procedure. For example, a bonding procedure such as welding, brazing, crimping, heat treating, or the like, or any other suitable procedure may cause a portion of liner 32 (and/or tubular member 28) to extend into space 42 (e.g., liner 32 may partially melt and extend into space 42 and contact tubular member 28) so as to define a bonding member 44. This later “bonding member” 44, in addition to being termed a bonding member, may be equally described as a bonding pattern, bonding configuration, bonding arrangement, etc. Regardless of whether or not bonding member 44 is a distinct structural element or not, the term “bonding member” 44, as used in this disclosure, is understood to mean either of the general configurations described above (i.e., distinct structural element or bonding pattern), to the extent applicable. Furthermore, even though bonding members 44 are depicted as distinct structural elements in the figures, they are not intended to being limit as such as they may actually be either configuration. Consequently, any of the illustrations of bonding member herein may be understood to be structurally-distinct bonding members or bonding members that represent a bonding pattern, bonding configuration, bonding arrangement, etc.
Bonding members 44 may contact and attach outer surface 34 of liner 32 with inner surface 40 of tubular member 28. In addition to attaching liner 32 to tubular member 28, bonding member 44 may have other desirable attributes. For example, bonding member 44 may comprise points of contact between tubular member 28 and liner 32 so that forces (e.g., torsional forces) can be transferred between tubular member 28 and liner 32. This may allow tubular member 28 and liner 32 to perform their respective functions more in unity with one another.
In general, bonding member 44 are arranged so that they occupy a certain amount or portion of the volume defined by space 42. In some embodiments, bonding members 44, in combination, may occupy 50% or more of the volume. In other embodiments, bonding members 44, in combination, may occupy 50% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 40% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 30% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 20% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 10% or less of the volume. In some embodiments, it may be desirable for bonding members 44, in combination, to occupy as little of the volume of space 42 as possible while still allowing for tubular member 28 and liner 32 to function in a desirable manner and so that they satisfactorily perform their intended function.
The arrangement and configuration of bonding members 44 relative to liner 32 may also vary. For example, in some embodiments, bonding members 44 may extend circumferentially about (e.g., a complete 360 degrees) liner 32 as shown in
Turning now to
In some embodiments, all of the pairs of bonding members 44 are arranged in the same way so that one of the bonding members 44 from each pair longitudinally aligns. In other embodiments, at least some of the pairs of bonding members 44 are rotated relative to other pairs. For example, some embodiments of catheters 10 include a first pair of bonding members 44 arranged as shown in
Moreover, when bonding members 44 are arranged in pairs (or otherwise in groups that are disposed at the same longitudinal location), the bonding members 44 may each have the same “length” (i.e., they each extend the same radial distance about liner 32) as depicted in
Furthermore, in some embodiments, all of the groups of bonding members 44 have the same number of bonding members 44. In other embodiments, some of the groups of bonding members 44 have a different number of bonding members 44.
It can be appreciated that a vast array of possibilities exist for the arrangement of bonding members 44 that are within the spirit of the invention.
In some embodiments, the interval or distance between longitudinally adjacent bonding members 44 is fixed along the length of liner 32. For example, in some embodiments, the interval between longitudinally adjacent bonding members is in the range of about 15 centimeters or less, about 14 centimeters or less, about 13 centimeters or less, about 12 centimeters or less, about 11 centimeters or less, about 10 centimeters or less, about 9 centimeters or less, about 8 centimeters or less, about 7 centimeters or less, about 6 centimeters or less, about 5 centimeters or less, about 4 centimeters or less, about 3 centimeters or less, about 2 centimeters or less, about 1 centimeter or less, or any other suitable interval. This interval may be constant or may change along the length of liner 32. In at least some embodiments, at least a portion of the tubular member 28 overlaps with liner 34 and defines an overlapping portion. Along the overlapping portion, there may be at least one bonding member 44 disposed at intervals of about every 15 centimeters or less, about every 14 centimeters or less, about every 13 centimeters or less, about every 12 centimeters or less, about every 11 centimeters or less, about every 10 centimeters or less, about every 9 centimeters or less, about every 8 centimeters or less, about every 7 centimeters or less, about every 6 centimeters or less, about every 5 centimeters or less, about every 4 centimeters or less, about every 3 centimeters or less, about every 2 centimeters or less, about every 1 centimeter or less, or any other suitable interval along at least a portion of or the entire length of the overlapping portion.
In other embodiments, the interval can change along a portion or all of the length of liner 32. For example,
Turning now to
The direction or orientation of bonding member 344 may vary. For example, in some embodiments, bonding member 344 may be arranged so that it is angled in the same, consistent, direction. The direction may be either slanted toward the proximal end or the distal end of shaft 312. In other embodiments, the orientation of bonding member 344 may vary. For example, some portions may be angled (i.e., the pitch may be angled) toward the proximal end of shaft 312 while other portions may be angled toward the distal end. Furthermore, some embodiments may include some portions that are angled in the same direction but at a different angle. It can be appreciated that numerous variations in the arrangement of bonding member 344 are contemplated.
Bonding member 344 may have a width that may in the range of about 0.1 to 10 millimeters. For example, bonding member 344 may be about 5 millimeters or less in width. In addition, the pitch of bonding member 344 may be about 0.1 to 10 centimeters or about 0.5 to 5 centimeters. These dimensions are provided for illustration purpose and are not intended to be limiting.
As illustrated in
In other embodiments, bonding member 344 may include several discrete bonding members that, collectively, follow a helical or spiral pattern about liner 34. For example, one or more bonding members 344 may be disposed at a first longitudinal position, a second set of one or more bonding member 344 may be disposed at an adjacent longitudinal position, etc. The second and subsequent sets of bonding members 344 may rotate about liner 34 such that bonding members 344 follow a helical pattern. In some embodiments, adjacent sets of bonding member 344 may be rotated at an angle relative to one another. For example, adjacent sets of bonding member 344 may be rotated more than about 90 degrees, about 90 degrees or less, about 85 degrees or less, about 80 degrees or less, about 75 degrees or less, about 70 degrees or less, about 65 degrees or less, about 60 degrees or less, about 55 degrees or less, about 50 degrees or less, about 45 degrees or less, or any other suitable angle. Essentially any other suitable angle or arrangement may be utilized without departing from the spirit of the invention.
The arrangement of bonding member 344 may be related to the arrangement of slots 30. For example, various embodiments of arrangements and configurations of slots 30 are contemplated. In some embodiments, at least some, if not all of slots 30 are disposed at the same or a similar angle with respect to the longitudinal axis of the tubular member 28. Slots 30 can be disposed at an angle that is perpendicular, or substantially perpendicular, and/or can be characterized as being disposed in a plane that is normal to the longitudinal axis of tubular member 28. However, in other embodiments, slots 30 can be disposed at an angle that is not perpendicular, and/or can be characterized as being disposed in a plane that is not normal to the longitudinal axis of tubular member 28. Additionally, a group of one or more slots 30 may be disposed at different angles relative to another group of one or more slots 30. The distribution and/or configuration of slots 30 can also include, to the extent applicable, any of those disclosed in U.S. Pat. Publication No. US 2004/0181174, the entire disclosure of which is herein incorporated by reference.
Slots 30 may be provided to enhance the flexibility of tubular member 28 while still allowing for suitable torque transmission characteristics. Slots 30 may be formed such that one or more rings and/or turns interconnected by one or more segments and/or beams are formed in tubular member 28, and such rings and beams may include portions of tubular member 28 that remain after slots 30 are formed in the body of tubular member 28. Such an interconnected ring structure may act to maintain a relatively high degree of torsional stiffness, while maintaining a desired level of lateral flexibility. In some embodiments, some adjacent slots 30 can be formed such that they include portions that overlap with each other about the circumference of tubular member 28. In other embodiments, some adjacent slots 30 can be disposed such that they do not necessarily overlap with each other, but are disposed in a pattern that provides the desired degree of lateral flexibility.
Additionally, slots 30 can be arranged along the length of, or about the circumference of, tubular member 28 to achieve desired properties. For example, adjacent slots 30, or groups of slots 30, can be arranged in a symmetrical pattern, such as being disposed essentially equally on opposite sides about the circumference of tubular member 28, or can be rotated by an angle relative to each other about the axis of tubular member 28. Additionally, adjacent slots 30, or groups of slots 30, may be equally spaced along the length of tubular member 28, or can be arranged in an increasing or decreasing density pattern, or can be arranged in a non-symmetric or irregular pattern. Other characteristics, such as slot size, slot shape and/or slot angle with respect to the longitudinal axis of tubular member 28, can also be varied along the length of tubular member 28 in order to vary the flexibility or other properties. In other embodiments, moreover, it is contemplated that the portions of the tubular member, such as a proximal section, or a distal section, or the entire tubular member 28, may not include any such slots 30.
As suggested above, slots 30 may be formed in groups of two, three, four, five, or more slots 30, which may be located at substantially the same location along the axis of tubular member 28. Within the groups of slots 30, there may be included slots 30 that are equal in size (i.e., span the same circumferential distance around tubular member 28). In some of these as well as other embodiments, at least some slots 30 in a group are unequal in size (i.e., span a different circumferential distance around tubular member 28). Longitudinally adjacent groups of slots 30 may have the same or different configurations. For example, some embodiments of tubular member 28 include slots 30 that are equal in size in a first group and then unequally sized in an adjacent group. It can be appreciated that in groups that have two slots 30 that are equal in size, the beams (i.e., the portion of tubular member 28 remaining after slots 30 are formed therein) are aligned with the center of tubular member 28. Conversely, in groups that have two slots 30 that are unequal in size, the beams are offset from the center of tubular member 28. Some embodiments of tubular member 28 include only slots 30 that are aligned with the center of tubular member 28, only slots 30 that are offset from the center of tubular member 28, or slots 30 that are aligned with the center of tubular member 28 in a first group and offset from the center of tubular member 28 in another group. The amount of offset may vary depending on the depth (or length) of slots 30 and can include essentially any suitable distance.
Slots 30 can be formed by methods such as micro-machining, saw-cutting (e.g., using a diamond grit embedded semiconductor dicing blade), laser cutting, electron discharge machining, grinding, milling, casting, molding, chemically etching or treating, or other known methods, and the like. In some such embodiments, the structure of the tubular member 28 is formed by cutting and/or removing portions of the tube to form slots 30. Some example embodiments of appropriate micromachining methods and other cutting methods, and structures for tubular members including slots and medical devices including tubular members are disclosed in U.S. Pat. Publication Nos. US 2003/0069522 and US 2004/0181174-A2; and U.S. Pat. Nos. 6,766,720; and 6,579,246, the entire disclosures of which are herein incorporated by reference. Some example embodiments of etching processes are described in U.S. Pat. No. 5,106,455, the entire disclosure of which is herein incorporated by reference. It should be noted that the methods for manufacturing catheter 10 may include forming slots 30 in tubular member 28 using any of these or other manufacturing steps.
Numerous other arrangements are contemplated that take advantage of the various arrangements and/or configurations discussed above.
Referring back now to the arrangement of bonding member 344 relative to the arrangement of slots 30, slots 30 and/or the beams formed in tubular member 28 may follow a pattern about tubular member 28. For example, in some embodiments, the beams may follow a spiral or helical pattern about tubular member 28. In other embodiments, the beams may be longitudinally aligned, follow any other suitable pattern, or be disposed in any suitable arrangement.
Turning back now to
With the above arrangements of various bonding members and the like in mind, it should be noted that any of the arrangements disclosed above can be combined with one another in various embodiments of catheters.
Other variations are contemplated for the various structures disclosed herein including suitable materials. Catheter 10 as well as the various components and variations thereof may include a number of different materials including metals, metal alloys, polymers (some examples of which are disclosed below), metal-polymer composites, combinations thereof, and the like, or any other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: NO6625 such as INCONEL® 625, UNS: NO6022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: NO4400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; combinations thereof; and the like; or any other suitable material.
As alluded to above, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear that the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.
In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also can be distinguished based on its composition), which may accept only about 0.2-0.44% strain before plastically deforming.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensitelaustenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60° C. to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties and has essentially no yield point.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of catheter 10, for example markers 26, may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of catheter 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like.
In some embodiments, a degree of MRI compatibility is imparted into catheter 10. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make all or portions of catheter 10, in a manner that would impart a degree of MRI compatibility. For example, tubular member 28 or portions thereof, or any other portion of catheter 10, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Tubular member 28 or portions thereof, or any other portion of catheter 10, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.
A sheath or covering (not shown) may be disposed over portions or all of catheter 10 that may define a generally smooth outer surface for catheter 10. In other embodiments, however, such a sheath or covering may be absent from a portion of all of catheter 10. The sheath may be made from a polymer or any other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP).
The sheath, if present, and/or liner 32 may be made from a lubricious, hydrophilic, protective, or other type of material. Alternatively, liner may include any other suitable material or combination of materials including any of those disclosed herein. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which improves device handling and device exchanges. Lubricious coatings improve steerability and improve lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.
The coating and/or sheath may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), or fusing several segments end-to-end. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Number | Name | Date | Kind |
---|---|---|---|
1553227 | Feyk et al. | Sep 1925 | A |
1866888 | Hawley | Jul 1932 | A |
2275827 | Plensler | Mar 1942 | A |
2413805 | Vickers | Jan 1947 | A |
2441166 | Raspert | May 1948 | A |
2561890 | Stoddard | Jul 1951 | A |
2722614 | Fryklund | Nov 1955 | A |
2857536 | Light | Oct 1958 | A |
2864017 | Waltscheff | Dec 1958 | A |
2871793 | Michie et al. | Feb 1959 | A |
3249776 | Anderson et al. | May 1966 | A |
3322984 | Anderson | May 1967 | A |
3334253 | Hill | Aug 1967 | A |
3363470 | Yavne | Jan 1968 | A |
3452227 | Welch | Jun 1969 | A |
3452742 | Muller | Jul 1969 | A |
3463953 | Maxwell | Aug 1969 | A |
3512019 | Durand | May 1970 | A |
3544868 | Bates | Dec 1970 | A |
3625200 | Muller | Dec 1971 | A |
3686990 | Margolien | Aug 1972 | A |
3841308 | Tate | Oct 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3906938 | Fleischhacker | Sep 1975 | A |
4000672 | Sitterer et al. | Jan 1977 | A |
4003369 | Heilman et al. | Jan 1977 | A |
4020829 | Willson et al. | May 1977 | A |
4142119 | Madey | Feb 1979 | A |
4215703 | Wilson | Aug 1980 | A |
4330725 | Hintz | May 1982 | A |
4425919 | Alston, Jr. et al. | Jan 1984 | A |
4476754 | Ducret | Oct 1984 | A |
4482828 | Vergues et al. | Nov 1984 | A |
4516972 | Samson | May 1985 | A |
4545390 | Leary | Oct 1985 | A |
4563181 | Wijayarathna et al. | Jan 1986 | A |
4574670 | Johnson | Mar 1986 | A |
4580551 | Siegmund et al. | Apr 1986 | A |
4583404 | Bernard et al. | Apr 1986 | A |
4635270 | Gürs | Jan 1987 | A |
4665906 | Jervis | May 1987 | A |
4676249 | Arenas et al. | Jun 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4737153 | Shimamura et al. | Apr 1988 | A |
4763647 | Gambale | Aug 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4781092 | Gaiser | Nov 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4786220 | Fildes et al. | Nov 1988 | A |
4790331 | Okada et al. | Dec 1988 | A |
4800890 | Cramer | Jan 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827941 | Taylor et al. | May 1989 | A |
4831858 | Yoshizawa | May 1989 | A |
4832047 | Sepetka et al. | May 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4846193 | Tremulis et al. | Jul 1989 | A |
4867173 | Leoni | Sep 1989 | A |
4875489 | Messner et al. | Oct 1989 | A |
4884579 | Engelson | Dec 1989 | A |
4911148 | Sosnowski et al. | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922164 | Jacobsen et al. | May 1990 | A |
4922777 | Kawabata | May 1990 | A |
4932959 | Horzewski et al. | Jun 1990 | A |
4934380 | Toledo | Jun 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
4954022 | Underwood et al. | Sep 1990 | A |
4955384 | Taylor et al. | Sep 1990 | A |
4955862 | Sepetka | Sep 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4964409 | Tremulis | Oct 1990 | A |
4966163 | Kraus et al. | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
4973321 | Michelson | Nov 1990 | A |
4981478 | Evard et al. | Jan 1991 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4989608 | Ratner | Feb 1991 | A |
4990143 | Sheridan | Feb 1991 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5007434 | Doyle et al. | Apr 1991 | A |
5009137 | Dannatt | Apr 1991 | A |
5040543 | Badera et al. | Aug 1991 | A |
5050606 | Tremulis | Sep 1991 | A |
5052404 | Hodgson | Oct 1991 | A |
5059177 | Alcebo et al. | Oct 1991 | A |
5063935 | Gambale | Nov 1991 | A |
5065769 | De Toledo | Nov 1991 | A |
5095915 | Engelson | Mar 1992 | A |
5106455 | Jacobsen et al. | Apr 1992 | A |
5109830 | Cho | May 1992 | A |
5125395 | Adair | Jun 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5144959 | Gambale et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5176660 | Truckai | Jan 1993 | A |
5180376 | Fischell | Jan 1993 | A |
5181668 | Tsuji et al. | Jan 1993 | A |
5205830 | Dassa et al. | Apr 1993 | A |
5211183 | Wilson | May 1993 | A |
5228441 | Lundquist | Jul 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242759 | Hall | Sep 1993 | A |
5243996 | Hall | Sep 1993 | A |
5250069 | Nobuyoshi et al. | Oct 1993 | A |
5254106 | Feaster | Oct 1993 | A |
5254107 | Soltesz | Oct 1993 | A |
5256144 | Kraus et al. | Oct 1993 | A |
5257974 | Cox | Nov 1993 | A |
5259393 | Corso, Jr. et al. | Nov 1993 | A |
5267979 | Appling et al. | Dec 1993 | A |
5267982 | Sylvanowicz | Dec 1993 | A |
5279562 | Sirhan et al. | Jan 1994 | A |
5284128 | Hart | Feb 1994 | A |
5300032 | Hibbs et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5306252 | Yutori et al. | Apr 1994 | A |
5308435 | Ruggles et al. | May 1994 | A |
5315906 | Ferenczi et al. | May 1994 | A |
5315996 | Lundquist | May 1994 | A |
5318529 | Kontos | Jun 1994 | A |
5322064 | Lundquist | Jun 1994 | A |
5329923 | Lundquist | Jul 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5334145 | Lundquist et al. | Aug 1994 | A |
5336205 | Zenzen et al. | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5354623 | Hall | Oct 1994 | A |
5358493 | Schweich et al. | Oct 1994 | A |
5358796 | Nakamura et al. | Oct 1994 | A |
5365942 | Shank | Nov 1994 | A |
5365943 | Jansen | Nov 1994 | A |
5368564 | Savage | Nov 1994 | A |
5368661 | Nakamura et al. | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5381782 | DeLaRama et al. | Jan 1995 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5411476 | Abrams | May 1995 | A |
5425723 | Wang | Jun 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5438993 | Lynch et al. | Aug 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441483 | Avitall | Aug 1995 | A |
5441489 | Utsumi et al. | Aug 1995 | A |
5447812 | Fukuda et al. | Sep 1995 | A |
5454787 | Lundquist | Oct 1995 | A |
5454795 | Samson | Oct 1995 | A |
5458605 | Klemm | Oct 1995 | A |
5460187 | Daigle et al. | Oct 1995 | A |
5460608 | Lodin et al. | Oct 1995 | A |
5470330 | Goldenberg et al. | Nov 1995 | A |
5476701 | Berger | Dec 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5496294 | Hergenrother et al. | Mar 1996 | A |
5497785 | Viera | Mar 1996 | A |
5507301 | Wasicek et al. | Apr 1996 | A |
5507729 | Lindenberg et al. | Apr 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5507766 | Kugo et al. | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5520194 | Miyata et al. | May 1996 | A |
5520645 | Imran et al. | May 1996 | A |
5531719 | Takahashi | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5546958 | Thorud et al. | Aug 1996 | A |
5551444 | Finlayson | Sep 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5562619 | Mirarchi et al. | Oct 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569200 | Umeno et al. | Oct 1996 | A |
5569218 | Berg | Oct 1996 | A |
5571073 | Castillo | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5584821 | Hobbs et al. | Dec 1996 | A |
5599326 | Carter | Feb 1997 | A |
5599492 | Engelson | Feb 1997 | A |
5601539 | Corso, Jr. | Feb 1997 | A |
5603705 | Berg | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5622184 | Ashby et al. | Apr 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5656011 | Uihlein et al. | Aug 1997 | A |
5658264 | Samson et al. | Aug 1997 | A |
5666968 | Imran et al. | Sep 1997 | A |
5666969 | Urick et al. | Sep 1997 | A |
5669926 | Aust et al. | Sep 1997 | A |
5674208 | Berg et al. | Oct 1997 | A |
5676659 | McGurk | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5680873 | Berg et al. | Oct 1997 | A |
5682894 | Orr et al. | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5702373 | Samson | Dec 1997 | A |
5720300 | Fagan et al. | Feb 1998 | A |
5722609 | Murakami | Mar 1998 | A |
5728063 | Preissman et al. | Mar 1998 | A |
5733248 | Adams et al. | Mar 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5746701 | Noone | May 1998 | A |
5769830 | Parker | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5788653 | Lorenzo | Aug 1998 | A |
5788654 | Schwager | Aug 1998 | A |
5788707 | Del Toro et al. | Aug 1998 | A |
5792124 | Horrigan et al. | Aug 1998 | A |
5797856 | Frisbie et al. | Aug 1998 | A |
5800454 | Jacobsen et al. | Sep 1998 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5807249 | Qin et al. | Sep 1998 | A |
5810885 | Zinger | Sep 1998 | A |
5813996 | St. Germain et al. | Sep 1998 | A |
5827225 | Ma Schwab | Oct 1998 | A |
5827242 | Follmer et al. | Oct 1998 | A |
5830155 | Frechette et al. | Nov 1998 | A |
5833631 | Nguyen | Nov 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5836926 | Peterson et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843244 | Pelton et al. | Dec 1998 | A |
5851203 | van Muiden | Dec 1998 | A |
5853400 | Samson | Dec 1998 | A |
5860963 | Azam et al. | Jan 1999 | A |
5891114 | Chien et al. | Apr 1999 | A |
5895378 | Nita | Apr 1999 | A |
5897537 | Berg et al. | Apr 1999 | A |
5902254 | Magram | May 1999 | A |
5902290 | Peacock, III et al. | May 1999 | A |
5904657 | Unsworth et al. | May 1999 | A |
5906618 | Larson, III | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5916177 | Schwager | Jun 1999 | A |
5916178 | Noone | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5980471 | Jafari | Nov 1999 | A |
6001068 | Uchino et al. | Dec 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6014919 | Jacobsen et al. | Jan 2000 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6022369 | Jacobsen et al. | Feb 2000 | A |
6024730 | Pagan | Feb 2000 | A |
6027461 | Walker et al. | Feb 2000 | A |
6042553 | Solar et al. | Mar 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6053903 | Samson | Apr 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6063200 | Jacobsen et al. | May 2000 | A |
6066361 | Jacobsen et al. | May 2000 | A |
6106485 | McMahon | Aug 2000 | A |
6106488 | Fleming et al. | Aug 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6152912 | Jansen et al. | Nov 2000 | A |
6159187 | Park et al. | Dec 2000 | A |
6165292 | Abrams et al. | Dec 2000 | A |
6171296 | Chow | Jan 2001 | B1 |
6183410 | Jacobsen et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6197014 | Samson et al. | Mar 2001 | B1 |
6203485 | Urick | Mar 2001 | B1 |
RE37148 | Shank | Apr 2001 | E |
6212422 | Berg et al. | Apr 2001 | B1 |
6214042 | Jacobsen et al. | Apr 2001 | B1 |
6228073 | Noone et al. | May 2001 | B1 |
6240231 | Ferrera et al. | May 2001 | B1 |
6248082 | Jafari | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6254549 | Ramzipoor | Jul 2001 | B1 |
6260458 | Jacobsen et al. | Jul 2001 | B1 |
6273404 | Holman et al. | Aug 2001 | B1 |
6273876 | Klima et al. | Aug 2001 | B1 |
6273879 | Keith et al. | Aug 2001 | B1 |
6290656 | Boyle et al. | Sep 2001 | B1 |
6296616 | McMahon | Oct 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6302870 | Jacobsen et al. | Oct 2001 | B1 |
6325790 | Trotta | Dec 2001 | B1 |
6338725 | Hermann et al. | Jan 2002 | B1 |
6346091 | Jacobsen et al. | Feb 2002 | B1 |
6352515 | Anderson et al. | Mar 2002 | B1 |
6355005 | Powell et al. | Mar 2002 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6368316 | Jansen et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6375774 | Lunn et al. | Apr 2002 | B1 |
6379369 | Abrams et al. | Apr 2002 | B1 |
6390993 | Cornish et al. | May 2002 | B1 |
6398758 | Jacobsen et al. | Jun 2002 | B1 |
6428489 | Jacobsen et al. | Aug 2002 | B1 |
6428512 | Anderson et al. | Aug 2002 | B1 |
6431039 | Jacobsen et al. | Aug 2002 | B1 |
6440088 | Jacobsen | Aug 2002 | B1 |
6478778 | Jacobsen et al. | Nov 2002 | B1 |
6488637 | Eder et al. | Dec 2002 | B1 |
6491648 | Cornish et al. | Dec 2002 | B1 |
6491671 | Larson, III et al. | Dec 2002 | B1 |
6503244 | Hayman | Jan 2003 | B2 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6508806 | Hoste | Jan 2003 | B1 |
6524301 | Wilson et al. | Feb 2003 | B1 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6547779 | Levine et al. | Apr 2003 | B2 |
6553880 | Jacobsen et al. | Apr 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6602207 | Mann et al. | Aug 2003 | B1 |
6602280 | Chobotov | Aug 2003 | B2 |
6610046 | Usami et al. | Aug 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6636758 | Sanchez et al. | Oct 2003 | B2 |
6638266 | Wilson et al. | Oct 2003 | B2 |
6652508 | Griffin et al. | Nov 2003 | B2 |
6682493 | Mirigian | Jan 2004 | B2 |
6689120 | Gerdts | Feb 2004 | B1 |
6702762 | Jafari et al. | Mar 2004 | B2 |
6712826 | Lui | Mar 2004 | B2 |
6730095 | Olson, Jr. et al. | May 2004 | B2 |
6746422 | Noriega | Jun 2004 | B1 |
6749560 | Konstorum et al. | Jun 2004 | B1 |
6766720 | Jacobsen et al. | Jul 2004 | B1 |
6777644 | Peacock, III et al. | Aug 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6837898 | Boyle et al. | Jan 2005 | B2 |
6866642 | Kellerman et al. | Mar 2005 | B2 |
6866665 | Orbay | Mar 2005 | B2 |
6887235 | O'Connor et al. | May 2005 | B2 |
6896671 | Vitullo et al. | May 2005 | B2 |
6918882 | Skujins et al. | Jul 2005 | B2 |
6997937 | Jacobsen et al. | Feb 2006 | B2 |
7001369 | Griffin et al. | Feb 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
7153277 | Skujins et al. | Dec 2006 | B2 |
7182735 | Shireman et al. | Feb 2007 | B2 |
7850623 | Griffin | Dec 2010 | B2 |
20020013540 | Jacobsen et al. | Jan 2002 | A1 |
20020019599 | Rooney et al. | Feb 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030060732 | Jacobsen et al. | Mar 2003 | A1 |
20030069522 | Jacobsen | Apr 2003 | A1 |
20030216668 | Howland et al. | Nov 2003 | A1 |
20040045645 | Zhou | Mar 2004 | A1 |
20040082879 | Klint | Apr 2004 | A1 |
20040116831 | Vrba | Jun 2004 | A1 |
20040142643 | Miller et al. | Jul 2004 | A1 |
20040167436 | Reynolds et al. | Aug 2004 | A1 |
20040167437 | Sharrow et al. | Aug 2004 | A1 |
20040167440 | Sharrow | Aug 2004 | A1 |
20040167441 | Reynolds et al. | Aug 2004 | A1 |
20040181174 | Davis et al. | Sep 2004 | A2 |
20040181176 | Jafari et al. | Sep 2004 | A1 |
20040181207 | Vitullo et al. | Sep 2004 | A1 |
20040193140 | Griffin et al. | Sep 2004 | A1 |
20050027309 | Shiber | Feb 2005 | A1 |
20050177073 | Shiber | Aug 2005 | A1 |
20050288628 | Jordan et al. | Dec 2005 | A1 |
20060111649 | Zhou | May 2006 | A1 |
20060121218 | Obara et al. | Jun 2006 | A1 |
20060122537 | Reynolds et al. | Jun 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20060264904 | Kerby et al. | Nov 2006 | A1 |
20070100285 | Griffin et al. | May 2007 | A1 |
20070100424 | Chew et al. | May 2007 | A1 |
20080021347 | Jacobsen et al. | Jan 2008 | A1 |
20080021348 | Jacobsen et al. | Jan 2008 | A1 |
20080021400 | Jacobsen et al. | Jan 2008 | A1 |
20080021401 | Jacobsen et al. | Jan 2008 | A1 |
20080021402 | Jacobsen et al. | Jan 2008 | A1 |
20080021403 | Jacobsen et al. | Jan 2008 | A1 |
20080021404 | Jacobsen et al. | Jan 2008 | A1 |
20080021405 | Jacobsen et al. | Jan 2008 | A1 |
20080021406 | Jacobsen et al. | Jan 2008 | A1 |
20080021407 | Jacobsen et al. | Jan 2008 | A1 |
20080021408 | Jacobsen et al. | Jan 2008 | A1 |
20080077119 | Snyder et al. | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
723040 | Dec 1997 | AU |
733966 | Apr 1998 | AU |
9712829 | Jan 2000 | BR |
2266685 | May 2006 | CA |
2255781 | Mar 2007 | CA |
1230914 | Oct 1999 | CN |
2539191 | Mar 1976 | DE |
285514 | Dec 1990 | DE |
0 045 931 | Feb 1982 | EP |
0 069 522 | Jan 1983 | EP |
0 087 933 | Sep 1983 | EP |
0 111 044 | Jun 1984 | EP |
0 181 174 | May 1986 | EP |
0 377 453 | Jul 1990 | EP |
0 565 065 | Jun 1996 | EP |
0 778 038 | Jun 1997 | EP |
0 778 039 | Jun 1997 | EP |
0 778 040 | Jun 1997 | EP |
0 812 599 | Dec 1997 | EP |
0 823 262 | Feb 1998 | EP |
0 865 772 | Sep 1998 | EP |
0 865 773 | Sep 1998 | EP |
0 521 595 | May 1999 | EP |
0 917 885 | May 1999 | EP |
0 937 481 | Aug 1999 | EP |
0 790 066 | Apr 2000 | EP |
0 608 853 | Apr 2003 | EP |
0 935 947 | Dec 2004 | EP |
0 934 141 | Nov 2005 | EP |
0215173 | Dec 2008 | EP |
2214354 | Aug 1989 | GB |
2257269 | Jan 1993 | GB |
58-8522 | Jan 1983 | JP |
60091858 | May 1985 | JP |
61022752 | Jan 1986 | JP |
62023361 | Jan 1987 | JP |
62089470 | Apr 1987 | JP |
62299277 | Dec 1987 | JP |
6393516 | Apr 1988 | JP |
63-181774 | Jul 1988 | JP |
63217966 | Sep 1988 | JP |
1089956 | Apr 1989 | JP |
1135363 | May 1989 | JP |
1158936 | Jun 1989 | JP |
2107268 | Apr 1990 | JP |
3081831 | Apr 1991 | JP |
03-122850 | Dec 1991 | JP |
4061840 | Feb 1992 | JP |
4099963 | Mar 1992 | JP |
4213069 | Aug 1992 | JP |
4213070 | Aug 1992 | JP |
4236965 | Aug 1992 | JP |
5149969 | Jun 1993 | JP |
5-506806 | Oct 1993 | JP |
5-309159 | Nov 1993 | JP |
5-507857 | Nov 1993 | JP |
6-501179 | Feb 1994 | JP |
631749 | Apr 1994 | JP |
6169996 | Jun 1994 | JP |
6-63224 | Sep 1994 | JP |
6312313 | Nov 1994 | JP |
728562 | May 1995 | JP |
7124164 | May 1995 | JP |
7124263 | May 1995 | JP |
7136280 | May 1995 | JP |
7148264 | Jun 1995 | JP |
7505561 | Jun 1995 | JP |
7037199 | Jul 1995 | JP |
7185009 | Jul 1995 | JP |
7255855 | Oct 1995 | JP |
7275366 | Oct 1995 | JP |
751067 | Nov 1995 | JP |
8-229888 | Sep 1996 | JP |
8509141 | Oct 1996 | JP |
8317988 | Dec 1996 | JP |
9000164 | Apr 1997 | JP |
9-276413 | Oct 1997 | JP |
9276413 | Oct 1997 | JP |
9-294813 | Nov 1997 | JP |
9294813 | Nov 1997 | JP |
10-118193 | May 1998 | JP |
10328191 | Dec 1998 | JP |
11-267224 | Oct 1999 | JP |
2000-197704 | Jul 2000 | JP |
2000-510722 | Aug 2000 | JP |
2000-511083 | Aug 2000 | JP |
2001-500808 | Jan 2001 | JP |
3325828 | Jul 2002 | JP |
2002-529137 | Sep 2002 | JP |
2002-542901 | Dec 2002 | JP |
2002-543896 | Dec 2002 | JP |
2003-517893 | Jun 2003 | JP |
3649604 | Feb 2005 | JP |
2005-534407 | Nov 2005 | JP |
712908 | Jan 1980 | SU |
758421 | Aug 1980 | SU |
1529365 | Dec 1989 | SU |
WO 9002520 | Mar 1990 | WO |
WO 9113364 | Sep 1991 | WO |
WO 9204072 | Mar 1992 | WO |
WO 9207619 | May 1992 | WO |
WO 9304722 | Mar 1993 | WO |
WO 9311313 | Jun 1993 | WO |
WO 9524236 | Sep 1995 | WO |
WO 9619255 | Jun 1996 | WO |
9638193 | Dec 1996 | WO |
WO 9710022 | Mar 1997 | WO |
WO 9725914 | Jul 1997 | WO |
WO 9743949 | Nov 1997 | WO |
WO 9744083 | Nov 1997 | WO |
WO 9744086 | Nov 1997 | WO |
WO 9810694 | Mar 1998 | WO |
WO 9904847 | Feb 1999 | WO |
WO 9911313 | Mar 1999 | WO |
WO 0027303 | May 2000 | WO |
WO 0030710 | Jun 2000 | WO |
WO 0045885 | Aug 2000 | WO |
WO 0048645 | Aug 2000 | WO |
WO 0057943 | Oct 2000 | WO |
WO 0066199 | Nov 2000 | WO |
WO 0067845 | Nov 2000 | WO |
WO 0072907 | Dec 2000 | WO |
WO 0128620 | Apr 2001 | WO |
WO 0136034 | May 2001 | WO |
0145912 | Jun 2001 | WO |
WO 0145773 | Jun 2001 | WO |
WO 0193920 | Dec 2001 | WO |
WO 0213682 | Feb 2002 | WO |
WO 02062540 | Aug 2002 | WO |
WO 03004086 | Jan 2003 | WO |
WO 03008148 | Jan 2003 | WO |
03041783 | May 2003 | WO |
2004012804 | Feb 2004 | WO |
WO 04012804 | Feb 2004 | WO |
WO 2004012804 | Feb 2004 | WO |
WO 04033015 | Apr 2004 | WO |
WO 2004033015 | Apr 2004 | WO |
2004047899 | Jun 2004 | WO |
WO 04093957 | Nov 2004 | WO |
WO 2004093957 | Nov 2004 | WO |
2007050718 | May 2007 | WO |
2008034010 | Mar 2008 | WO |
Entry |
---|
“Mechanical Design and Systems Handbook”, H.A. Rothbart, 1964, p. 33-13 (one sheet). |
Number | Date | Country | |
---|---|---|---|
20090043283 A1 | Feb 2009 | US |